Common Epilepsy, Migraine Drug Topiramate Won't Raise Odds for Autism in Offspring
THURSDAY, March 21, 2024 -- A common antiseizure drug used to treat epilepsy, migraines and bipolar disorder does not appear to increase the risk of autism for kids exposed to it in the womb, a new study says.
Topiramate does not contribute to any... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2024 Category: General Medicine Source Type: news
Autism Risk May Rise With In Utero Exposure to Antiseizure Meds
WEDNESDAY, March 20, 2024 -- The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy compared with the general population of children without exposure to antiseizure medications in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 20, 2024 Category: Pharmaceuticals Source Type: news
New Data Fuel Debate on Autism and Prenatal Topiramate Exposure
(MedPage Today) -- The incidence of autism spectrum disorder was higher among children exposed to topiramate in the second half of pregnancy than in the general population, but not relative to other children born to women with epilepsy, a study... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 20, 2024 Category: Neurology Source Type: news
PRAC Recommends New Restrictions on Topiramate in Pregnancy PRAC Recommends New Restrictions on Topiramate in Pregnancy
The EMA safety committee recommends new measures to limit topiramate use in young women based on recent data suggesting more neurodevelopmental disorders for offspring when it ' s used during pregnancy.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 5, 2023 Category: Psychiatry Tags: Neurology & Neurosurgery News Alert Source Type: news
Prenatal Exposure to Phentermine-Topiramate Lower Under Safety Program
TUESDAY, March 21, 2023 -- Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2023 Category: Pharmaceuticals Source Type: news
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat?
(MedPage Today) -- After major shortages of semaglutide (Ozempic), the 0.25 mg, 0.5 mg, and 1 mg doses are back on shelves. The 2 mg dose still has limited availability until the end of March. (Reuters)
Prenatal exposure to phentermine-topiramate... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 21, 2023 Category: Endocrinology Source Type: news
Recommending Exercise for Migraine: Just Do It Recommending Exercise for Migraine: Just Do It
Strength training is the most effective form of exercise for reducing migraine, with high-intensity aerobics coming in second, but both beat top-line migraine meds topiramate and amitriptyline, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - November 22, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
U.K. Health Authority Investigates Epilepsy Drug's Link to Autism
The Medicines and Healthcare products Regulatory Agency's investigation comes after a study showed prenatal exposure to topiramate roughly triples a child's likelihood of having autism or intellectual disability. (Source: The Scientist)
Source: The Scientist - August 30, 2022 Category: Science Tags: News & Opinion Source Type: news
FDA Expands Use of Weight-Loss Drug to Adolescents
(MedPage Today) -- The FDA approved a supplemental indication for phentermine/topiramate extended-release capsules (Qsymia) for chronic weight management in adolescents ages 12 and older with obesity, defined as a body mass index (BMI) in the 95th... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 28, 2022 Category: American Health Source Type: news
FDA approves treatment for chronic weight management in pediatric patients aged 12 years and older
The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are obese, defined as a body mass index (BMI) of 95th percentile or greater w (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 27, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older
June 27, 2022 -- The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 27, 2022 Category: Drugs & Pharmacology Source Type: news
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 31, 2022 Category: Psychiatry Tags: Family Medicine, Gynecology, Neurology, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
TUESDAY, May 31, 2022 -- Prenatal exposure to topiramate, valproate, and certain duotherapies is associated with increased risks for autism spectrum disorder (ASD) and intellectual disability (ID), according to a study published online May 31 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2022 Category: Pharmaceuticals Source Type: news
Erenumab Bests Topiramate in First Head-to-Head Migraine Trial Erenumab Bests Topiramate in First Head-to-Head Migraine Trial
The calcitonin-gene related peptide receptor inhibitor erenumab is more effective and tolerable than topiramate for treating migraine, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 19, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Eprontia (Topiramate Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 17, 2021 Category: Drugs & Pharmacology Source Type: news
